As the rollout of COVID-19 vaccines unfolds in the U.S., numerous questions around distribution, supply, hesitancy and efficacy persist. The stakes are high, as numbers of deaths and cases break records.
A panel of experts from Harvard and the Centers for Disease Control and Prevention tackles questions about COVID-19 vaccination.
